Sale in the works for local firm Michrom Bioresources
Massachusetts-based Bruker Corp. has signed an agreement to purchase Michrom Bioresources Inc., a 22
Read more on The Sacramento Bee
US biotech firm Genzyme valued at $20.1 bln in sweetened all-cash takeover by Sanofi-Aventis
PARIS – French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the market in lucrative drugs for rare genetic disorders.
Read more on Minneapolis-St. Paul Star Tribune
Agribusiness firm Syngenta merging two divisions after strong year
Agribusiness giant Syngenta is merging its seeds and crop protection divisions to boost sales and reduce costs. The Swiss company, which has a major presence in the Triangle and in Greensboro, announced its reorganization plan today in conjunction with its release of full year 2010 results that exceeded analysts’ expectations.
Read more on The News & Observer
Bay Biz Buzz: Xoma to develop diabetes drug with French firm
Berkeley-based Xoma Ltd., an unprofitable 30-year- old biotechnology company, will get an initial payment of $35 million and may earn as much as $800 million more from Les Laboratoires Servier to share development of a medicine for diabetes and other disorders.
Read more on Inside Bay Area
Biotech firm a success story
SPRINGFIELD – By making it easier to measure how individual cells produce and consume energy, Seahorse Bioscience dreams of helping researchers around the globe uncover the causes of diabetes, obesity, cancer, Parkinson’s and Alzheimer’s.
Read more on The Republican
RTP biotech firm Precision BioSciences moves HQ to Durham
Durham, N.C. — Precision BioSciences , which is focused on genetic research, now calls downtown Durham its home. The company moved into new headquarters space at Scientific Properties, which is owned by Venable Center.
Read more on Local Tech Wire
U.S. biotech firm targeted
French drug giant Sanofi-Aventis SA on Sunday launched a $18.5 billion cash bid for American biotech firm Genzyme Corp. – a move that follows months of rumored interest and failed attempts to bring Genzyme’s management to the table.
Read more on Fort Wayne Journal Gazette
Biofuels Firm KiOR Exceeds Offering, Closes at $110M – cbl
By citybizlist Staff PASADENA, Texas — Biofuels company KiOR has raised $110 million from 13 invest…
Read more on citybizlist Houston
Product Description
This digital document is an article from San Fernando Valley Business Journal, published by CBJ, L.P. on April 14, 2003. The length of the article is 952 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Firm takes different course.(biotech companies seek new funding)
Author: Carlos Martinez
Publication: San Fernando Valley Business Journal (Magazine/Journal)
Date: April 14, 2003
Publisher: CBJ, L.P.
Volume: 8 Issue: 8 Page: 1(2)
Distributed by Thomson Gale
Firm takes different course.: An article from: San Fernando Valley Business Journal
As part of the strategic portfolio alignment Tecan sells sample management business to US firm NEXUS Biosystems
MANNEDORF, SWITZERLAND–(Marketwire – July 15, 2010) – As part of the strategic portfolio alignment Tecan sells sample management business to US firm NEXUS Biosystems. Processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement
Read more on Marketwire
Powered by Yahoo! Answers
